Overview

RGD-PET-CT in Cancer Angiogenesis

Status:
Terminated

Trial end date:
2015-09-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to look at 2 new methods of scanning and see whether they can help researchers predict which tumours will respond to drugs that attack tumour blood supply.

Phase:

Phase 2

Details

Lead Sponsor:

Oxford University Hospitals NHS Trust

Collaborators:

GE Healthcare
University of Oxford

Treatments:

Angiogenesis Inhibitors